Mike Hooven is the President & Chief Executive Officer, Enable Injections, has more than 30 years of experience in the medical device industry in a broad variety of technical and clinical areas. He is the founder of five medical device companies and holds over 100 issued and pending US patents.
Mr Hooven is the founder, and a director of AtriCure, Inc (Nasdaq ATRC), a medical device company that manufactures and sells surgical devices to treat the most serious forms of atrial fibrillation. AtriCure has grown rapidly to become the market leader, with over 200,000 procedures performed. AtriCure completed a successful IPO in 2005. He previously held positions as the Chairman and CEO of AtriCure, and the Founder and Chairman of Enable Medical, a surgical device manufacturer that was acquired by AtriCure in August of 2005.
Mr Hooven founded Enable in 1994 and, prior to that, he headed up all internal product development at Ethicon Endo-Surgery from 1988 to 1994. He held engineering positions at Siemens/Pacesetter from 1986 to 1988, and at Cordis Corporation from 1981 to 1986. He earned a BS in Physics and an MSc in Mechanical Engineering from the University of Michigan (Ann Arbor, MI, US).